StreetAlpha
13F holdings · Q3 2026

Blue Water Life Science Advisors

Larkspur, CA · files as Blue Water Life Science Advisors, LP
Know the moment Blue Water Life Science Advisors filesYou follow Blue Water Life Science Advisors An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1789778

Blue Water Life Science Advisors reported 8 stocks worth $252M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are CDNA (45.0%), TXG (14.1%) and ADPT (11.6%). Compared with Q2 2026, the fund added to CDNA, GH and BLLN, trimmed TXG and sold out of PSNL.

Latest filing: what Blue Water Life Science Advisors did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
0 new3 added1 trimmed1 sold outBought about $46M · sold about $45.1M
New 0

None

Added 3
Trimmed 1
  • TXG−$22.6M−39%
Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$252M+58.5% vs last quarter
Stocks held80 new · 1 sold out
Top 5 weight87.0%very concentrated
Turnover36%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
CDNA
Caredx Inc
$113M45.0%1.7M+550K (+46%)8 of 8
2
TXG
10X Genomics Inc
$35.4M14.1%391K−251K (−39%)4 of 8
3
ADPT
Adaptive Biotechnologies Cor
$29.2M11.6%1MNo change8 of 8
4
GH
Guardant Health Inc
$27.1M10.8%152K+37K (+32%)8 of 8
5
NTRA
Natera Inc
$14.3M5.7%34KNo change8 of 8
6
QTRX
Quanterix Corp
$12.9M5.1%3.5MNo change8 of 8
7
BLLN
Billiontoone Inc
$11.1M4.4%104K+34K (+49%)3 of 8
8
TEM
Tempus AI Inc
$8.6M3.4%105KNo change6 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
PSNL
Personalis Inc
$22.5M1.7M

Reported value

last 8 quarters
$113MQ4 '24
$101MQ1 '25
$126MQ2 '25
$110MQ3 '25
$159MQ4 '25
$125MQ1 '26
$159MQ2 '26
$252MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Blue Water Life Science Advisors 13F FAQ

What does Blue Water Life Science Advisors own?

Blue Water Life Science Advisors reported 8 stocks worth $252M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are CDNA (45.0%), TXG (14.1%) and ADPT (11.6%). The table above lists every position in the filing (the top 10 without an account).

What did Blue Water Life Science Advisors buy and sell in Q3 2026?

Compared with Q2 2026: 0 new positions, 3 added to, 1 trimmed and 1 sold out. It sold all of PSNL.

When will Blue Water Life Science Advisors file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Blue Water Life Science Advisors's portfolio worth?

The Q3 2026 filing reports $252M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.